Goldman Small Cap Research

AI stocks are the hottest segment of the market and for good reason. A new report is out today on an under the radar AI firm abt to surge higher as well. Sybleu (Ticker: SYBE) is an AI-driven drug discovery firm in the lucrative vet health market. This industry segment has peers that boast huge valuations ranging from 27x - 100x revenue---and it looks like SYBE is on the same path as it reaches a series of milestones in the coming months. Investors have an insatiable appetite for these stocks and continue to raise hundreds of millions for them. That is why we believe SYBE could join the party by year-end.

Under-the-Radar AI-Driven Biotech to Surge Higher Emerging AI-Driven Biotech Sybleu, Inc. (OTC:SYBE) offers competitive advantages and upcoming milestones in the stock market's top-followed and funded segment, AI, prompting a potential surge in the s

New report on award-winning smart gym equip maker and digital health services co. Interactive Strength, Inc. d/b/a FORME (NASDAQ: TRNR). Co. just signed an LOI for an acquisition that we believe is transformative for TRNR. It will dramatically accelerate high rev growth/profit. Thus, the deal could lead to major stock gains ahead. TRNR closed @ $1.23, trades only 0.7x sales--artificially low valuation. Now a great entry point. Our target is $4.15, and reflects a reasonable 3x 2024E sales.

TRNR: High Growth, Low Valuation Stock Offers Major Upside Interactive Strength, Inc. (NASDAQ: TRNR) d/b/a FORME is about to make a profound change in its business that will prompt major growth, accelerate profit, and drive the artificially low valuation subs

New report on a company undergoing a major transformation--driving annual rev growth from $162M in 2022 to $913M in 2023, with $0.30 in adjusted EPS. Muscle Maker Inc. (NASDAQ:GRIL) is fast becoming a major player in the global food supply chain, with 2 distinct business lines. Our 6-9 month conservative target is 3x recent prices, with more potential upside in the cards. Given its rapid transformation, and huge growth, GRIL could be the most talked about play on NASDAQ this year.

Transformed GRIL Set for Record Growth Muscle Maker, Inc. (NASDAQ: GRIL) is set to grow revenue from $162M in 2022 to over $1B in 2024, with a substantial rise in adjusted net income, thereby driving its share price to new highs